Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 894

Document Document Title
WO/2018/119101A1
A flow cell package includes first and second surface-modified patterned wafers and a spacer layer. The first surface-modified patterned wafer includes first depressions separated by first interstitial regions, a first functionalized mol...  
WO/2018/102517A1
Disclosed herein are compositions for use in an energy providing devices and methods of preparing such devices. Also included herein is energy providing devices that comprise a charged compound modified substrate or zwitterion-modified s...  
WO/2017/131097A1
Provided is a pharmaceutical composition for the treatment or prevention of a cognitive disease or disorder, the composition comprising a compound represented by formula (1), an enantiomer thereof or diasteriomer thereof, or a pharmaceut...  
WO/2017/131236A1
The present invention relates to the nucleic acid complex expressed by formula 1. Formula 1: (In formula 1, X is an oligonucleotide, L1 and L2 each independently represents a sugar ligand, and S1, S2 and S3 each independently represents ...  
WO/2017/089492A1
The present invention concerns a method of synthesizing a iodo- or astatoarene comprising the reaction of a diaryliodonium compound with a iodide or astatide salt, respectively. The invention also relates to said iodo- or astatoarene and...  
WO/2017/081069A1
The present invention relates to tri-functional crosslinking reagents carrying (i) a ligand-reactive group for conjugation to a ligand of interest having at least one binding site on a target glycoprotein receptor, (ii) a hydrazone group...  
WO/2017/057461A1
A production method for producing an aldehyde compound or a ketone compound by oxidizing a primary or secondary alcohol compound, wherein the alcohol compound has, in the molecule thereof, a group selected from an amino group, an azide g...  
WO/2016/180297A1
The present invention relates to the fields of organic chemistry and metal organic chemistry, disclosed are a metal bridge site fused ring compound, and an intermediate, a preparation method and a use thereof, the metal bridge site fused...  
WO/2016/127023A1
Neat 4-azidobutylamine and sails of 4-azidobutylamine and processes for producing the same are described herein. Amines represent a large class of organic compounds containing a basic nitrogen atom having a lone pair of electrons and one...  
WO/2016/113764A4
The present invention relates to one step room temperature process for the synthesis of azido alcohols from alkenes. More particularly, I2 catalysed a regio and diastereo selective one step room temperature process for the synthesis of 1...  
WO/2016/113764A1
The present invention relates to one step room temperature process for the synthesis of azido alcohols from alkenes. More particularly, I2 catalysed a regio and diastereo selective one step room temperature process for the synthesis of 1...  
WO/2016/103283A1
The present invention provides bio-based aromatic diisocyanate of formula (I). [Formula should be inserted here] wherein X is –OCH3, Y is selected from -H or –OCH3, and m = 0-12. The present invention further provides a method for pr...  
WO/2016/058056A1
The invention discussed in this application relates to hydroxamic acid-based compounds that are useful as imaging agents when bound to an appropriate metal centre, particularly for the imaging of tumours.  
WO/2016/007726A1
By either forming a triaryl acid halide or a triaryl mixed anhydride and subsequently treating with aqueous sodium azide, triaryl acyl azides are prepared in high yield using inexpensive reagents in a process in which by-products are eas...  
WO/2015/122494A1
Provided is a novel compound having an excellent suppression action against arrhythmia including atrial fibrillation and being useful as a pharmaceutical product having a separated antiviral effect. A compound indicated by general formul...  
WO/2015/044177A1
The present invention refers to compounds of formula: (formula A), wherein R1 is selected from (formula I), (formula II), (formula (III), (formula IV), (formula V), or (formula B), and wherein R2, R3, R4 and R5 are as defined in the clai...  
WO/2015/043493A1
The present invention relates to a 5-formylcytosine specific chemical labeling method and related applications in aspects such as sequencing, detection, imaging, and diagnosis. In the method, a condensation reaction occurs between an act...  
WO/2015/019192A3
There are provided pyrrolysine analogues of the formulae (X), (I), (II), (V), (VI), (VII) and (VIII), in which the a, b, d, X, Y, Z, FG, R, R1, R2 and R3 are as defined in the claims, which are useful in bioconjugation processes and muta...  
WO/2015/004563A1
The present invention provides compounds of formula (1) a process for their preparation, a solution comprising these compounds, a process for the preparation of a device using the solution, devices obtainable by the process and the use o...  
WO/2015/006728A3
The present invention relates to methods and reagents for use in site-selective modification of proteins having lysine residues with functionalized peptides using a chemoenzymatic microbial transglutaminase-mediated reaction. The functio...  
WO/2014/197991A8
The present application describes amphiphatic compounds like compound Ila below, compositions and methods for incorporating chemoselective and bio-orthogonal complementary functional groups into liposomes. Such compounds are incorporated...  
WO/2014/197991A1
The present application describes amphiphatic compounds like compound Ila below, compositions and methods for incorporating chemoselective and bio-orthogonal complementary functional groups into liposomes. Such compounds are incorporated...  
WO/2014/158209A1
The present invention provides a method for converting an aromatic hydrocarbon to a phenol by providing an aromatic hydrocarbon comprising one or more aromatic C-H bonds and one or more activated C-H bonds in a solvent; adding a phthaloy...  
WO/2014/073001A1
The application discloses monomers based on bis phenols with pendent reactive azido groups. The application further provides a process for preparation of bisphenol monomers with pendent reactive azido groups which are used further for pr...  
WO/2014/072992A1
The present invention relates to process for preparing triazole compounds used in the treatment of epilepsy. The process comprises of reacting compound of 2, 6 difluoroazide (II) with 2, 3 dihalo compound (III) to form compound of formul...  
WO/2014/044873A1
There are provided amino acid derivatives of formula V and VI as defined herein which are pyrrolysine analogs for use in bioconjugation processes.  
WO/2014/036492A1
Provided herein are modified amino acids comprising an azido group, polypeptides, antibodies and conjugates comprising the modified amino acids, and methods of producing the polypeptides, antibodies and conjugates comprising the modified...  
WO/2014/011753A3
Rhein analogues that exhibit anti-proliferative activity, particular against cancer cells, are described herein. In some embodiments, the compounds contain a flat or planar ring system. Such rings system by facilitate non-covalent bindin...  
WO/2013/187325A1
The present invention provides a method for producing an azide compound. The method is characterized by producing an azide compound in the form of a solution, the azide compound being represented by general formula (I) (wherein, Y repres...  
WO/2013/153873A1
A photosensitive compound represented by formula (1) or formula (2). (Chemical formula 1) (In formula (1) and formula (2), n is an integer of 1-3; R1 is a linear or branched alkyl group having 1-6 carbon atoms or an alkylene group having...  
WO/2013/144979A1
The present invention relates to an improved process for the preparation of Aliskiren and its pharmaceutically acceptable salts comprising reducing the compound of Formula-Z in presence of catalyst and ammonia. The present invention furt...  
WO/2013/127949A1
Functional PLA-PEG copolymers, the nanoparticles thereof, their preparation and use for targeted drug delivery and imaging The present invention concerns novel functional PEG-PLA containing copolymers, the nanoparticles containing the sa...  
WO/2013/093943A1
Disclosed herein is a single step catalytic process for the production of enantiomerically pure ?-Aryloxy-?'-Azido/Alkoxy alcohols of formula (A). The invention, in particular discloses phenolytic kinetic resolution of racemic anti and s...  
WO/2013/093943A9
Disclosed herein is a single step catalytic process for the production of enantiomerically pure α-Aryloxy-α'-Azido/Alkoxy alcohols of formula (A). The invention, in particular discloses phenolytic kinetic resolution of racemic anti and...  
WO/2013/087498A1
This invention pertains to fluoroallylsulfonyl azide compounds of formula: CF2=CF-CF2-O-Rf-SO2N3 formula (I) wherein Rf is a divalent (per)fluorinated group, optionally comprising one or more than one ethereal oxygen atom [monomer (Az)],...  
WO/2013/081237A1
The present invention provides a (meta) acryloyl iminophosphazene compound represented by chemical formula 1, a method for manufacturing same, and a copolymer and a composition comprising same. The (meta) acryloyl iminophosphazene compou...  
WO/2013/061340A1
The present invention discloses high yielding enantioselective process for synthesis of Oseltamivir from readily available starting material, cis-1,4-butene diol.The process features incorporation of chirality using sharpless asymmetric ...  
WO/2013/054273A9
The present invention provides a process for the preparation of agomelatine and its intermediate compounds. The invention also provides intermediate compounds of agomelatine represented by Formula IV, Formula V and Formula VIII.  
WO/2013/054273A2
The present invention provides a process for the preparation of agomelatine and its intermediate compounds. The invention also provides intermediate compounds of agomelatine represented by Formula IV, Formula V and Formula VIII. Formula ...  
WO/2013/054273A3
The present invention provides a process for the preparation of agomelatine and its intermediate compounds. The invention also provides intermediate compounds of agomelatine represented by Formula IV, Formula V and Formula VIII.  
WO/2012/121396A1
This fluorescent compound contains a switch moiety which is represented by formula (1) and a chelator moiety which can chelate a rare earth element bound to A1 and/or A2 in formula (1).  
WO/2012/092718A1
Compounds of the formula (I) are provided, wherein the stereochemical configuration of the double bond "a" is cis-or trans-, Ak is an alkylenyl, and R is a series of two or more naturally occurring or synthetic amino acid residues. The c...  
WO/2012/052829A1
The present invention provides novel process for the preparation of renin inhibitor Aliskiren or its derivatives, and its pharmaceutically acceptable salts. The present invention also provides novel intermediates used in the preparation ...  
WO/2012/034065A1
The present invention provides aliskiren intermediates and impurities, and processes for preparation thereof. The present invention also provides processes for preparing aliskiren using these intermediates and impurities. These impuritie...  
WO/2012/014226A1
The present invention discloses novel process for the preparation of (2R)-2-acetamido-N- benzyl-3-methoxypropanamide of Formula I involving novel intermediates of Formula - XIX and Formula - XX.  
WO/2011/162859A1
A method of forming an azido energetic alcohol includes converting an energetic diol to a cyclic sulfite, oxidizing the cyclic sulfite to a cyclic sulfate, and opening the cyclic sulfate. The cyclic sulfate is opened, followed by hydroly...  
WO/2011/148392A1
The present invention relates to a process for the preparation of (2S,4S,5S,7S)-N-(2- Carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl- 8-[4-methoxy-3-(3-methoxy propoxy )phenyl]-octanamide compound of formula- 1 and its pharm...  
WO/2011/149620A2
Various methods and structures of complexes and molecules are described herein related to a zinc-centered catalyst for removing carbon dioxide from atmospheric or aqueous environments. According to one embodiment, a method for creating a...  
WO/2011/149620A3
Various methods and structures of complexes and molecules are described herein related to a zinc-centered catalyst for removing carbon dioxide from atmospheric or aqueous environments. According to one embodiment, a method for creating a...  
WO/2011/116371A3
Compositions comprising linear PNAI, cyclic PNAI, linear PEI, and/or cyclic PEI, useful for delivering compounds or substances into a cell, are provided, as well as methods of making linear PNAI, cyclic PNAI, linear PEI, and cyclic PEI. ...  

Matches 1 - 50 out of 894